Cite
HARVARD Citation
Carey, I. et al. (n.d.). PMO-155 Low pre-treatment HBsAG plasma levels, on therapy HBsAG levels decline and IP-10 concentrations increase predict response to treatment in tolerant children with chronic hepatitis B. Gut. p. A136. [Online].